Krzyścin, M.; Sowińska-Przepiera, E.; Gruca-Stryjak, K.; Soszka-Przepiera, E.; Syrenicz, I.; Przepiera, A.; Bumbulienė, Ž.; Syrenicz, A.
Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications? Biomedicines 2024, 12, 1034.
https://doi.org/10.3390/biomedicines12051034
AMA Style
Krzyścin M, Sowińska-Przepiera E, Gruca-Stryjak K, Soszka-Przepiera E, Syrenicz I, Przepiera A, Bumbulienė Ž, Syrenicz A.
Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications? Biomedicines. 2024; 12(5):1034.
https://doi.org/10.3390/biomedicines12051034
Chicago/Turabian Style
Krzyścin, Mariola, Elżbieta Sowińska-Przepiera, Karolina Gruca-Stryjak, Ewelina Soszka-Przepiera, Igor Syrenicz, Adam Przepiera, Žana Bumbulienė, and Anhelli Syrenicz.
2024. "Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?" Biomedicines 12, no. 5: 1034.
https://doi.org/10.3390/biomedicines12051034
APA Style
Krzyścin, M., Sowińska-Przepiera, E., Gruca-Stryjak, K., Soszka-Przepiera, E., Syrenicz, I., Przepiera, A., Bumbulienė, Ž., & Syrenicz, A.
(2024). Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications? Biomedicines, 12(5), 1034.
https://doi.org/10.3390/biomedicines12051034
